ロード中...
Reintroduction of Imatinib in GIST
PURPOSE: This review examines the clinical evidence showing that imatinib can be prescribed to treat recurrence or progression of gastrointestinal stromal tumors (GIST) in patients who interrupted first-line imatinib therapy in the adjuvant or advanced/metastatic setting. METHODOLOGY: A literature s...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3825279/ https://ncbi.nlm.nih.gov/pubmed/23921604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12029-013-9532-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|